Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Leukemia. 2013 Apr 23;28(1):118–128. doi: 10.1038/leu.2013.125

Figure 6. Up-regulation of survival gene expression in CD19 positive B cells from CLL patient samples with 17p deletion.

Figure 6

A Mcl-1, Bcl-XL and Bcl-2 protein levels in CD19 positive B cells from CLL patients with or without 17p deletion (3 17p WT samples and 4 17p− samples).

B Mcl-1 mRNA levels in in CD19 positive B cells from CLL patients with or without 17p deletion (3 17p WT samples and 4 17p− samples).

C Bcl-XL mRNA levels in in CD19 positive B cells from CLL patients with or without 17p deletion (3 17p WT samples and 4 17p− samples).

D Bcl-2 mRNA levels in in CD19 positive B cells from CLL patients with or without 17p deletion (3 17p WT samples and 4 17p− samples).